Study on detection of insulin autoimmune antibodies: limitation and countermeasures

doi:10.16150/j.1671-2870.2022.01.018

Abstract

Abstract:

Insulin autoimmune antibodies (IAA) detection are commonly applied to diagnosis of type 1 diabetes mellitus(T1DM), prediction of incidence risk and disease outcomes. It can also be used for the diagnosis of insulin autoimmune syndrome (IAS) and exogenous insulin antibodies syndrome (EIAS). The problem is that IAA has different subtypes which may lead to uncertainties in the prediction and diagnosis of T1DM since the existing clinical detection technology is limited to subdivide them. Meanwhile, the diabetes complicated with IAS or T1DM complicated with EIAS bring more difficulty in detecting IAA subtype as differentiating endogenous etiology(T1DM and IAS) from exogenous etiology (EIAS). In recent years, the studies on IAA affinity, isotype and antigenic epitope may enable laboratory detection to classify IAA groups, which is worth paying attention to.

Key words: Type 1 diabetes, Insulin antibodies, Insulin autoimmunity syndrome, Exogenous insulin antibody positive syndrome

CLC Number:

R587.1

CHEN Xuyang, GU Weiqiong. Study on detection of insulin autoimmune antibodies: limitation and countermeasures[J]. Journal of Diagnostics Concepts & Practice, 2022, 21(01): 95-98.

References 23

[1]	Cappellani D, Macchia E, Falorni A, et al. Insulin Autoimmune Syndrome (Hirata Disease): A Comprehensive Review Fifty Years After Its First Description[J]. Diabetes Metab Syndr Obes, 2020, 13:963-978. doi: 10.2147/DMSO.S219438 URL
[2]	Huynh T. Clinical and Laboratory Aspects of Insulin Autoantibody-Mediated Glycaemic Dysregulation and Hyperinsulinaemic Hypoglycaemia: Insulin Autoimmune Syndrome and Exogenous Insulin Antibody Syndrome[J]. Clin Biochem Rev, 2020, 41(3):93-102. doi: 10.33176/AACB-20-00008 pmid: 33343044
[3]	Achenbach P, Schlosser M, Williams AJ, et al. Combined testing of antibody titer and affinity improves insulin autoantibody measurement: Diabetes Antibody Standardization Program[J]. Clin Immunol, 2007, 122(1):85-90. pmid: 17059894
[4]	Barker JM, Barriga KJ, Yu L, et al. Prediction of autoantibody positivity and progression to type 1 diabetes: Diabetes Autoimmunity Study in the Young(DAISY)[J]. J Clin Endocrinol Metab, 2004, 89(8):3896-3902. doi: 10.1210/jc.2003-031887 URL
[5]	Achenbach P, Warncke K, Reiter J, et al. Stratification of type 1 diabetes risk on the basis of islet autoantibody characteristics[J]. Diabetes, 2004, 53(2):384-392. pmid: 14747289
[6]	Pöllänen PM, Ryhänen SJ, Toppari J, et al. Dynamics of Islet Autoantibodies During Prospective Follow-Up From Birth to Age 15 Years[J]. J Clin Endocrinol Metab, 2020, 105(12):e4638-e4651. doi: 10.1210/clinem/dgaa624 URL
[7]	Frontino G, Guercio Nuzio S, Scaramuzza A, et al. Prevention of type 1 diabetes: where we are and where we are going[J]. Minerva Pediatr (Torino), 2021, 73(6):486-503.
[8]	周方励, 田浩明. 糖尿病患者外源性胰岛素诱导胰岛素抗体产生的临床意义[J]. 实用医院临床杂志, 2014, 11(1):18-21.
	Zhou FL, Tian H M. Clinical significance of insulin antibody production induced by exogenous insulin in patients with diabetes[J]. Clin J Pract Hosp, 2014, 11(1):18-21.
[9]	Yu L, Zhao Z, Steck AK. T1D Autoantibodies: room for improvement?[J]. Curr Opin Endocrinol Diabetes Obes, 2017, 24(4):285-291. doi: 10.1097/MED.0000000000000348 URL
[10]	Potter KN, Wilkin TJ. The molecular specificity of insulin autoantibodies[J]. Diabetes Metab Res Rev, 2000, 16(5):338-353. doi: 10.1002/1520-7560(2000)9999:9999<::AID-DMRR145>3.0.CO;2-L URL
[11]	Hu X, Chen F. Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients[J]. Endocr Connect, 2018, 7(1):R47-R55. doi: 10.1530/EC-17-0309 URL
[12]	Jerkins T, Bell DSH. Development of Exogenous Insulin Antibody Syndrome in a Patient with Newly Diagnosed Type 1 Diabetes Successfully Treated with Oral Immunosuppressive Monotherapy[J]. Diabetes Ther, 2021, 12(10):2795-2799. doi: 10.1007/s13300-021-01129-4 pmid: 34403116
[13]	Achenbach P, Koczwara K, Knopff A, et al. Mature high-affinity immune responses to (pro)insulin anticipate the autoimmune cascade that leads to type 1 diabetes[J]. J Clin Invest, 2004, 114(4):589-597. pmid: 15314696
[14]	Eguchi Y, Uchigata Y, Yao K, et al. Longitudinal changes of serum insulin concentration and insulin antibody features in persistent insulin autoimmune syndrome (Hirata's disease)[J]. Autoimmunity, 1994, 19(4):279-284. pmid: 7578855
[15]	Ma WY, Won JG, Tang KT, et al. Severe hypoglycemic coma due to insulin autoimmune syndrome[J]. J Chin Med Assoc, 2005, 68(2):82-86. doi: 10.1016/S1726-4901(09)70140-6 URL
[16]	Kaneko K, Satake C, Izumi T, et al. Enhancement of postprandial endogenous insulin secretion rather than exo-genous insulin injection ameliorated insulin antibody-induced unstable diabetes: a case report[J]. BMC Endocr Disord, 2019, 19(1):5. doi: 10.1186/s12902-018-0326-3 pmid: 30621663
[17]	Bodansky HJ, Grant PJ, Dean BM, et al. Islet-cell antibodies and insulin autoantibodies in association with common viral infections[J]. Lancet, 1986, 2(8520):1351-1353. pmid: 2878223
[18]	Bonifacio E, Scirpoli M, Kredel K, et al. Early autoantibody responses in prediabetes are IgG1 dominated and suggest antigen-specific regulation[J]. J Immunol, 1999, 163(1):525-532. pmid: 10384157
[19]	Nell LJ, Hulbert C, Thomas JW. Human insulin autoantibody fine specificity and H and L chain use[J]. J Immunol, 1989, 142(9):3063-3069. pmid: 2468712
[20]	Kanatsuna N, Papadopoulos GK, Moustakas AK, et al. Etiopathogenesis of insulin autoimmunity[J]. Anat Res Int, 2012, 2012:457546.
[21]	Spanier JA, Sahli NL, Wilson JC, et al. Increased Effector Memory Insulin-Specific CD4 + T Cells Correlate With Insulin Autoantibodies in Patients With Recent-Onset Type 1 Diabetes[J]. Diabetes, 2017, 66(12):3051-3060. doi: 10.2337/db17-0666 pmid: 28842400
[22]	Matsushita S, Takahashi K, Motoki M, et al. Allele specificity of structural requirement for peptides bound to HLA-DRB10405 and -DRB10406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome[J]. J Exp Med, 1994, 180(3):873-883. doi: 10.1084/jem.180.3.873 pmid: 8064238
[23]	Devendra D, Galloway TS, Horton SJ, et al. The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes[J]. Diabetologia, 2003, 46(6):802-809. pmid: 12783163